Cohere and Aleph Alpha have signed a definitive business combination agreement to create a transatlantic sovereign AI company. The unified entity will maintain dual headquarters in Toronto and Berlin, expand to over 1,000 employees, and operate under Canadian and German regulatory frameworks to address sovereignty requirements for governments and regulated industries.
State attorneys general led by California's Rob Bonta settled their antitrust lawsuit against Paramount's $110 billion acquisition of Warner Bros. Discovery, clearing the way for the merger to close in early October. In exchange, Paramount committed to releasing 30 films annually in theaters and establishing an editorial independence board for CBS News and CNN. The deal, involving Middle Eastern sovereign wealth funds and ties to President Trump, sparked political controversy over media concentration.
Cohere and Aleph Alpha are merging to create a sovereign AI alternative, combining Canadian and German expertise to serve enterprises and governments demanding data control and independence from single vendors. The partnership, backed by Schwarz Group's $600M investment, targets regulated sectors including finance, defense, and healthcare with secure, customizable AI solutions.
Paramount CEO David Ellison is threatening to relocate the company's headquarters from California to Georgia, Tennessee, or Texas over a state-led antitrust lawsuit blocking its proposed $110 billion merger with Warner Bros Discovery. California Attorney General Rob Bonta and other officials have accused Paramount of blackmail, while LA Mayor Karen Bass emphasized protecting entertainment industry jobs. The merger faces a trial date of March 2, with settlement discussions expected next month.
Paramount funded and leaked a study claiming California would lose 58,000 jobs and $21 billion annually if its $111 billion merger with Warner Brothers is blocked by antitrust lawsuits. The company has engaged in controversial tactics including threats to leave California, accusations of antisemitism against opponents, and funding a questionable study through an industry-sponsored organization designed to appear objective.